Literature DB >> 7429022

EEG developmental stages.

H T Epstein.   

Abstract

Data in the literature show that in humans the fraction of the total electroencephalographic (EEG) energy that appears in the alpha frequencies rises from about zero at birth to about 70% in adults. This rise is shown to occur mainly in 5 stages, the ages of which correlate with those of stages of increase in brain weight. Supporting the correlation are data on gender dimorphism in humans in both brain weight and EEG development, as well as limited data on development in kittens, rats, mice, and guinea pigs.

Entities:  

Mesh:

Year:  1980        PMID: 7429022     DOI: 10.1002/dev.420130608

Source DB:  PubMed          Journal:  Dev Psychobiol        ISSN: 0012-1630            Impact factor:   3.038


  5 in total

1.  EEG power spectral slope differs by ADHD status and stimulant medication exposure in early childhood.

Authors:  Madeline M Robertson; Sarah Furlong; Bradley Voytek; Thomas Donoghue; Charlotte A Boettiger; Margaret A Sheridan
Journal:  J Neurophysiol       Date:  2019-10-16       Impact factor: 2.714

2.  Gray Matter Growth Is Accompanied by Increasing Blood Flow and Decreasing Apparent Diffusion Coefficient during Childhood.

Authors:  N D Forkert; M D Li; R M Lober; K W Yeom
Journal:  AJNR Am J Neuroradiol       Date:  2016-04-21       Impact factor: 3.825

3.  Evaluation of the electroencephalogram in young cats.

Authors:  Melissa J Lewis; D Colette Williams; Charles H Vite
Journal:  Am J Vet Res       Date:  2011-03       Impact factor: 1.156

4.  No difference indicated in electroencephalographic power spectral analysis in 3- and 6-month-old infants fed soy- or milk-based formula.

Authors:  Hongkui Jing; R T Pivik; Janet M Gilchrist; Thomas M Badger
Journal:  Matern Child Nutr       Date:  2008-04       Impact factor: 3.092

5.  Narrow band quantitative and multivariate electroencephalogram analysis of peri-adolescent period.

Authors:  E I Rodríguez Martinez; C I Barriga-Paulino; M I Zapata; C Chinchilla; A M López-Jiménez; C M Gómez
Journal:  BMC Neurosci       Date:  2012-08-24       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.